Editorial
- PMID: 36572631
- PMCID: PMC9907468
- DOI: 10.1093/europace/euac230
Editorial
Conflict of interest statement
Conflict of interest: Dr Auricchio is a consultant to Boston Scientific, Cairdac, EP Solutions, Hylomorph, Medtronic, and XSpline; has received speaker fees from Boston Scientific, Medtronic, Microport CRM, Philips; participates in clinical trials sponsored by Boston Scientific, EPD-Philips, EP Solutions, Medtronic, Philips, and XSpine; and holds intellectual properties with Boston Scientific, Biosense Webster, and Microport CRM.
References
-
- Sutton R. The first European journal on cardiac electrophysiology and pacing, the European Journal of Cardiac Pacing and Electrophysiology. Europace 2011;13:1663–4. - PubMed
-
- Wilde AAM, Semsarian C, Márquez MF, Shamloo AS, Ackerman MJ, Ashley EA et al. Developed in partnership with and endorsed by the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS). EHRA/HRS/APHRS/LAHRS expert consensus statement on the state of genetic testing for cardiac diseases. Europace 2022;8:1307–67. - PMC - PubMed